Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05965336 · ClinicalTrials.gov registry record · NA

Walking Function in Diabetic Peripheral Neuropathy

A NA study of Diabetic Peripheral Neuropathy, sponsored by Florida Institute for Human and Machine Cognition.

Recruiting
Registry status
NA
Development phase
50
Enrollment target
1
Study location

NCT05965336: Recruiting NA study of Diabetic Peripheral Neuropathy, sponsored by Florida Institute for Human and Machine Cognition.

NCT05965336 is a NA study of Diabetic Peripheral Neuropathy that is actively recruiting participants, run by Florida Institute for Human and Machine Cognition. The registered enrollment target is 50 participants, below the 126-participant average among 17 other Diabetic Peripheral Neuropathy trials with a reported enrollment target (60% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05965336, a NA study of Diabetic Peripheral Neuropathy, is actively recruiting participants, sponsored by Florida Institute for Human and Machine Cognition.

RECRUITING
Registry status
NA
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to 1) examine the differences in walking function and movement patterns between individuals with diabetic peripheral neuropathy and healthy adults with no known conditions; 2) examine if receiving feedback on walking form will help change walking patterns; and 3) examine the feasibility, safety, and preliminary effects of walking training with feedback on walking function in individuals with diabetic peripheral neuropathy.

Primary Outcome

Plantar pressure is calculated in kilopascals (kPa) using a force sensor placed between the participant's foot and insole of their shoe. The peak plantar pressure in regions of interest (forefoot) will be calculated.

Interventions

  • OTHER Clinical Evaluation
  • OTHER Evaluation of Passive Ankle Stiffness
  • OTHER Gait Biomechanics
  • OTHER Gait Biofeedback
  • OTHER Plantar Pressure Biofeedback Gait Training

Study Locations (1)

Florida

  • Florida Institute for Human and Machine Cognition - Pensacola

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2024-12-05
Est. Completion 2027-03
Phase NA

What NCT05965336 shows while recruiting

NCT05965336 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 126-participant average among 17 other Diabetic Peripheral Neuropathy trials with a reported enrollment target (60% lower).

The record links to 1 condition, with Diabetic Peripheral Neuropathy appearing as the primary indexed condition, and to 5 interventions - of which Clinical Evaluation is the first listed.

NCT05965336 reports a single indexed study location in Florida.

Frequently Asked Questions

What is clinical trial NCT05965336 about?

NCT05965336 is a clinical study titled "Walking Function in Diabetic Peripheral Neuropathy". The purpose of this study is to 1) examine the differences in walking function and movement patterns between individuals with diabetic peripheral neuropathy and healthy adults with no known conditions; 2) examine if receiving feedback on walking form will help change walking patterns; and 3) examine...

What is the current status of trial NCT05965336?

This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2024-12-05. Estimated completion is 2027-03.

What conditions does trial NCT05965336 study?

This clinical trial studies the following conditions: Diabetic Peripheral Neuropathy.

What interventions are being tested in trial NCT05965336?

The interventions under investigation include: Clinical Evaluation (OTHER), Evaluation of Passive Ankle Stiffness (OTHER), Gait Biomechanics (OTHER), Gait Biofeedback (OTHER), Plantar Pressure Biofeedback Gait Training (OTHER).

Who is sponsoring clinical trial NCT05965336?

This trial is sponsored by Florida Institute for Human and Machine Cognition, which has 7 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05965336 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Diabetic Peripheral Neuropathy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05965336's enrollment target sits among peer trials

50 10th of 17 higher than 7 of 17 other Diabetic Peripheral Neuropathy trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Diabetic Peripheral Neuropathy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00200889 · 50 participants · Early Phase 1

    Mapping Auricular Vagus Nerve Circuitry

  • NCT00409435 · 50 participants · Phase 2

    A Study of Pyridostigmine in Postural Tachycardia Syndrome

  • NCT01202305 · 50 participants

    The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies

  • NCT01225913 · 50 participants · Phase 4

    Mechanism(s) of Airflow Limitation During Exacerbation of Asthma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05965336, the US trial registry maintained by the National Library of Medicine. NCT05965336 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.